Lucia Lope-De
Madrid, MD 28022, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Optimized size exclusion chromatography demonstrates that extracellular vesicles are the key RNA carriers of ALK translocations in non-small cell lung cancer cell line secretome and patient plasma.
Journal: Extracellular vesicles and circulating nucleic acids
Published: February 03, 2025
BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 19, 2024
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniques.
Journal: Molecular oncology
Published: January 04, 2023
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis.
Journal: Frontiers in oncology
Published: May 13, 2022
Cancer as an infective disease: the role of EVs in tumorigenesis.
Journal: Molecular oncology
Published: May 09, 2022
ALK-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing.
Journal: Clinical chemistry
Published: October 22, 2021
Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles.
Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Published: July 14, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026